Oncternal Therapeutics News

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wills Robert James

Apr 10 20:43 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wills Robert James

Apr 1 19:03 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HALE DAVID F

Feb 27 17:10 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wills Robert James

Feb 27 17:09 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BREITMEYER JAMES B

Feb 15 18:03 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Leavitt Chase C.

Feb 15 18:03 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Krishnan Rajesh

Feb 15 18:03 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yazji Salim

Feb 15 18:03 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer VINCENT RICHARD G

Feb 15 18:03 ET

Oncternal Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.85%)

Feb 13 22:40 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BREITMEYER JAMES B

Jan 5 00:00 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Leavitt Chase C.

Jan 5 00:00 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yazji Salim

Jan 5 00:00 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer VINCENT RICHARD G

Jan 5 00:00 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Krishnan Rajesh

Jan 5 00:00 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Leavitt Chase C.

Oct 4, 2023 17:01 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yazji Salim

Oct 4, 2023 17:01 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer BREITMEYER JAMES B

Oct 4, 2023 17:00 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer VINCENT RICHARD G

Oct 4, 2023 16:59 ET

Oncternal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Krishnan Rajesh

Oct 4, 2023 16:59 ET